Analyst Chalres Zhu works at GUGGENHEIM and is focused on the Healthcare sector with 38 price targets and ratings documented since 2019 spanning on 6 stocks. Analyst's average stock valuation to be materialised ratio is 22.22% with an average time for price targets to be met of 44 days.
Most recent stock forecast was given on MGNX, MacroGenics, Inc at 23-Nov-2022.
Chalres Zhu best performing recommendations are on ZYME (ZYMEWORKS INC).
The best stock recommendation documented was for ZYME (ZYMEWORKS INC) at 11/20/2019. The price target of $48 was fulfilled within 58 days with a profit of $9.24 (23.84%) receiving and performance score of 4.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
25
$12.57 (101.13%)
38
2 months 12 days ago
0/4 (0%)
$19.29 (89.70%)
Hold
13
$0.57 (4.59%)
11
7 months 27 days ago
2/5 (40%)
$14.13 (69.94%)
4
Buy
30
$17.57 (141.35%)
25
7 months 27 days ago
2/4 (50%)
$14.19 (89.75%)
141
Buy
44
$27.94 (173.97%)
46
1 years 2 months 19 days ago
0/2 (0%)
$14.68 (50.06%)
Buy
47
$34.57 (278.12%)
45
1 years 5 months 13 days ago
2/4 (50%)
$11.43 (38.58%)
85
